Sfoglia per Autore
Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates.
2005 Cicero AF; Derosa G; Miconi A; Laghi L; Nascetti S; Gaddi A.
Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Herat Study.
2005 Borghi C; Dormi A; Gaddi A; Cosentino E; Immordino V; Ambrosioni E
Physical activity and cardiovascular disease mortality: the Brisighella heart study
2005 D'Addato S.; Dormi A.; Bernardi R.; Borghi C.; Gaddi A.
Assocaition between hyperCKPemia and hypercholesterolemia in general population: casual phenotype or genic cluster?
2005 Lucicesare A; Cicero AFG; Bove M; Aronis K; Bernardi R; Gaddi A.
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients
2005 A.F.G., Cicero; G., Derosa; M., Bove; A., Lucicesare; L., Laghi; S., D'Addato; A.Gaddi.
Case Report: lipoproteina (A) is an indipendent risk factor for coronary artery disease: diagnosis and follow-up of a patient with high level of Lp(a) as only cardiovascular risk factor
2005 Bernardi R.; D'Addato S.; Dormi A.; Brillante R.; Laghi L.; Linarello S.; Grandi E.; Gaddi A.
Cost-effetiveness analysis of complementary care for hyperlipidameias
2005 Cicero AFG; Bove M; Lucicsare A; Laghi L; Gaddi AV.
Relative role of major risk factors for Type 2 Diabetes development in the historical cohort of the Brisighella Heart Study: an 8-years follow-up.
2005 CICERO AFG; DORMI A; NASCETTI S; Panourgia MP; Grandi E; DADDATO S; GADDI A.
Complementary and alternative medicine for hypertension. What evidence is there for herbalist suggestions?
2005 Cicero AFG; Gaddi A; Borghi C
Treatment of peripheral obstructive artery disease: a battle that could be winned also with drugs? [Trattamento dell'arteriopatia obliterante degli arti inferiori: Una battaglia che può essere vinta anche con i farmaci?]
2005 Gaddi AV; Cicero AF
Treatment of massive hypertriglyceridemia resistant to PUFA and fibrates: a possible role for the coenzyme Q10?
2005 Cicero AF; Derosa G; Miconi A; Laghi L; Nascetti S; Gaddi A.
Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone.
2005 Cicero AF; Derosa G; Gaddi A.
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride.
2005 Derosa G.; Cicero A.; D’Angelo A.; Gaddi A.; Ragonesi P.D.; Piccinni M.N.; Salvadeo S.; Ciccarelli L.; Pricolo F.; Ghelfi M.; Ferrari I.; Montagna L.; Fogari R.
Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardio-vascular disease: response to Beishuizen et al.
2005 Cicero AF; Gaddi AV; Derosa G.
Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial.
2005 Derosa G; Gaddi AV; Ciccarelli L; Fogari E; Ghelfi M; Ferrari I; Cicero AF.
Causes of statin interruption by hyperlipidaemic patients: the result of survey on 218 consecutive patients.
2005 Cicero AFG; Bove M; Lucicesare A; Laghi L; Linarello S; Bernardi R; Gaddi AV.
Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension.
2005 Derosa G; Cicero AF; Gaddi A; Mugellini A; Ciccarelli L; Fogari R.
Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
2005 Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R.
Piano Regionale della Prevenzione (2005-2008; volume 44)
2006 Esperti e Ricercatori della Regione Emilia Romagna: [..; Gaddi, A V; ..]
Combining natural treatments to reach lipid target in metabolic syndrome patients: A randomized clinical trial
2006 Lucicesare, A; Cicero, AFG; Derosa, G; Gaddi, AV
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile